Company Filing History:
Years Active: 2012-2013
Title: Helén Tuvesson Andersson: Innovator in Pharmaceutical Chemistry
Introduction
Helén Tuvesson Andersson is a notable inventor based in Lund, Sweden. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating various diseases. With a total of 2 patents, her work is recognized for its potential impact on healthcare.
Latest Patents
Andersson's latest patents focus on anthranilic acid derivatives. These compounds are characterized by specific formulas where X can be CH≡CH, CHO, or OCH, and Y can be hydrogen or a straight or branched C1-C6 alkyl. The compounds are designed to be useful in treating autoimmune diseases, inflammatory diseases, organ transplant rejection, and malignant neoplasia. Additionally, pharmaceutical compositions containing these compounds, methods of using them, and methods for their preparation are also included in her patents.
Career Highlights
Helén Tuvesson Andersson is currently associated with Chelsea Therapeutics, Inc., where she continues her innovative work in pharmaceutical research. Her contributions have been instrumental in advancing therapeutic options for patients suffering from complex medical conditions.
Collaborations
Andersson has collaborated with notable colleagues such as Ulf Vellmar and Ingrid Hallin. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Helén Tuvesson Andersson's work exemplifies the vital role of innovation in the pharmaceutical industry. Her patents and collaborations reflect her commitment to improving healthcare through scientific advancements.